Literature DB >> 14575384

Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: comparative study with myocardial perfusion, left ventricular function, and histopathological findings.

Kimimasa Saito1, Kan Takeda, Kyoko Imanaka-Yoshida, Hiroshi Imai, Takao Sekine, Yuko Kamikura.   

Abstract

UNLABELLED: We investigated myocardial fatty acid metabolism in taxan-induced myocardial damage in patients with advanced lung cancer. PATIENTS AND METHODS: Twenty-five patients with non-small-cell lung cancer were treated with taxan combined with carboplatin intravenously for three cycles. Myocardial SPECT imaging using 99mTc-methoxyisobutyl isonitrile (MIBI) and 123I-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP) was performed successively before and after chemotherapy. Regional uptake scores of BMIPP and MIBI were visually assessed and total uptake scores and the number of abnormal segments were calculated. Left ventricular ejection fraction (LVEF) was obtained by first-pass radionuclide angiocardiography using MIBI. Postmortem pathological examination was performed in 5 patients.
RESULTS: Total BMIPP uptake scores after chemotherapy were significantly lower than those before chemotherapy (23.4 +/- 3.4 vs. 26.6 +/- 0.8; p < 0.001). Mean LVEF showed a significant decrease after chemotherapy. Of the 25 patients, 4 exhibited a decrease in LVEF of more than 10%, 1 had a decrease in LVEF to below 50%, and 1 developed congestive heart failure. These 6 patients had significant decreases in total BMIPP uptake scores and increases in the number of abnormal segments as compared with the other 19 patients. Histopathological examination of myocardial tissue showed interstitial edema and disarrayed myocardial cells.
CONCLUSION: Taxan impairs myocardial fatty acid metabolism. 123I-BMIPP myocardial SPECT is useful for evaluating the cardiotoxicity induced by taxan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575384     DOI: 10.1007/BF03006439

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  11 in total

Review 1.  Cardio-oncology: the Nuclear Option.

Authors:  Jorge A Alvarez; Raymond R Russell
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 2.  Noninvasive imaging of cardiovascular injury related to the treatment of cancer.

Authors:  Suwat Kongbundansuk; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2014-08

Review 3.  Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.

Authors:  Diwakar Jain; Tauseef Ahmad; Mitchel Cairo; Wilbert Aronow
Journal:  Ann Transl Med       Date:  2017-09

Review 4.  Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.

Authors:  Diwakar Jain; Raymond R Russell; Ronald G Schwartz; Gurusher S Panjrath; Wilbert Aronow
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 5.  Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers.

Authors:  Dongqing Chen; Conagh Kelly; Tatt Jhong Haw; Janine M Lombard; Ina I C Nordman; Amanda J Croft; Doan T M Ngo; Aaron L Sverdlov
Journal:  Curr Heart Fail Rep       Date:  2021-11-03

6.  Effectiveness of Iodine-123 β-methyl-P-iodophenyl-pentadecanoic acid (BMIPP) Myocardial Scintigraphy for Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD) in Breast Cancer Patients.

Authors:  Yuko Harada; Kyosuke Shimada; Yukino Kubota; Miyoko Yamashita
Journal:  Cureus       Date:  2022-05-31

7.  The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.

Authors:  Raymond R Russell; Jonathan Alexander; Diwakar Jain; Indu G Poornima; Ajay V Srivastava; Eugene Storozynsky; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952

Review 8.  Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.

Authors:  Ronald G Schwartz; Diwakar Jain; Eugene Storozynsky
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

Review 9.  Nuclear imaging in detection and monitoring of cardiotoxicity.

Authors:  Carmen D'Amore; Paola Gargiulo; Stefania Paolillo; Angela Maria Pellegrino; Tiziana Formisano; Antonio Mariniello; Giuseppe Della Ratta; Elisabetta Iardino; Marianna D'Amato; Lucia La Mura; Irma Fabiani; Flavia Fusco; Pasquale Perrone Filardi
Journal:  World J Radiol       Date:  2014-07-28

Review 10.  Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.

Authors:  Hyungseop Kim; Woo-Baek Chung; Kyoung Im Cho; Bong-Joon Kim; Jeong-Sook Seo; Seong-Mi Park; Hak Jin Kim; Ju-Hee Lee; Eun Kyoung Kim; Ho-Joong Youn
Journal:  J Cardiovasc Ultrasound       Date:  2018-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.